down arrow

Ajanta Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE031B01049
  • NSEID: AJANTPHARM
  • BSEID: 532331
INR
2,634.40
8.15 (0.31%)
BSENSE

Dec 05

BSE+NSE Vol: 9.98 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
25.07
25.27
25.27
17.17
17.39
17.54
Share Warrants & Outstandings
Total Reserve
3,760.04
3,536.44
3,362.38
3,246.87
2,977.70
2,580.86
Shareholder's Funds
3,790.29
3,567.36
3,387.99
3,264.34
2,995.63
2,598.87
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
0.00
1.25
1.64
1.60
0.74
Secured Loans
0.00
0.00
1.25
1.64
1.60
0.74
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-75.91
-25.95
0.95
46.32
42.07
55.76
Other Long Term Liabilities
37.77
27.23
28.63
21.02
22.76
16.1
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
80.27
39.54
24.15
19.32
17.93
15.65
Total Non-Current Liabilities
42.13
40.82
54.98
88.30
84.36
88.25
Current Liabilities
Trade Payables
454.20
463.20
422.77
327.17
373.86
362.34
Other Current Liabilities
515.96
413.31
702.31
309.41
263.06
191.82
Short Term Borrowings
2.59
1.49
0.18
0.00
0.00
42.85
Short Term Provisions
23.35
17.76
14.02
10.81
11.71
9.16
Total Current Liabilities
996.10
895.76
1,139.28
647.39
648.63
606.17
Total Liabilities
4,828.52
4,503.94
4,582.25
4,000.03
3,728.62
3,293.29
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
2,677.45
2,279.29
2,183.12
2,102.04
2,012.54
0.00
Less: Accumulated Depreciation
1,006.06
880.50
767.54
668.71
572.55
0.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
1,671.39
1,398.79
1,415.58
1,433.33
1,439.99
1,371.90
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
176.27
256.45
209.47
152.86
108.19
131.86
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
25.24
18.58
25.10
33.51
8.90
21.67
Long Term Loans & Advances
21.48
18.09
15.88
43.64
45.49
30.20
Other Non Current Assets
0.48
0.71
1.36
1.98
6.24
95.95
Total Non-Current Assets
1,985.49
1,773.02
1,748.25
1,735.57
1,701.03
1,651.58
Current Assets Loans & Advances
Current Investments
438.71
330.05
510.27
121.86
175.67
67.14
Inventories
903.85
828.36
815.63
791.07
766.47
495.68
Sundry Debtors
1,182.74
1,246.84
1,056.90
1,019.81
738.43
775.30
Cash and Bank
176.24
130.77
330.90
211.79
209.61
205.25
Other Current Assets
76.82
110.37
68.70
78.15
102.39
68.67
Short Term Loans and Advances
64.67
84.53
51.60
41.78
35.02
29.67
Total Current Assets
2,843.03
2,730.92
2,834.00
2,264.46
2,027.59
1,641.71
Net Current Assets (Including Current Investments)
1,846.93
1,835.16
1,694.72
1,617.07
1,378.96
1,035.54
Total Current Assets Excluding Current Investments
2,404.32
2,400.87
2,323.73
2,142.60
1,851.92
1,574.57
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
4,828.52
4,503.94
4,582.25
4,000.03
3,728.62
3,293.29
Contingent Liabilities
8.12
4.94
4.55
7.28
82.90
50.13
Total Debt
0.00
1.49
1.43
1.64
1.60
43.59
Book Value per share (adjusted)
302.38
282.34
268.14
253.495023300155
229.681531210208
197.56
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 73.83% vs 4.20% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 38.71% vs -4.89% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 11.62% vs 1.86% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 35.84% vs -25.98% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 4.11% vs -3.64% in Mar 2024

Compare Balance Sheet Results of Ajanta Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
25.07
25.37
-0.30
-1.18%
Share Warrants & Outstandings
Total Reserve
3,760.04
6,920.38
-3,160.34
-45.67%
Shareholder's Funds
3,790.29
6,948.45
-3,158.16
-45.45%
Minority Interest
0.00
1,439.82
-1,439.82
-100.00%
Long-Term Borrowings
0.00
543.24
-543.24
-100.00%
Secured Loans
0.00
543.24
-543.24
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-75.91
278.05
-353.96
-127.30%
Other Long Term Liabilities
37.77
51.54
-13.77
-26.72%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
80.27
96.31
-16.04
-16.65%
Total Non-Current Liabilities
42.13
969.14
-927.01
-95.65%
Current Liabilities
Trade Payables
454.20
846.17
-391.97
-46.32%
Other Current Liabilities
515.96
512.42
3.54
0.69%
Short Term Borrowings
2.59
758.46
-755.87
-99.66%
Short Term Provisions
23.35
269.17
-245.82
-91.33%
Total Current Liabilities
996.10
2,386.22
-1,390.12
-58.26%
Total Liabilities
4,828.52
11,743.63
-6,915.11
-58.88%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2,677.45
6,754.01
-4,076.56
-60.36%
Less: Accumulated Depreciation
1,006.06
2,705.88
-1,699.82
-62.82%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1,671.39
4,048.13
-2,376.74
-58.71%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
176.27
616.17
-439.90
-71.39%
Intangible assets under development
0.00
5.60
-5.60
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
25.24
216.32
-191.08
-88.33%
Long Term Loans & Advances
21.48
308.63
-287.15
-93.04%
Other Non Current Assets
0.48
453.90
-453.42
-99.89%
Total Non-Current Assets
1,985.49
5,776.59
-3,791.10
-65.63%
Current Assets Loans & Advances
Current Investments
438.71
763.39
-324.68
-42.53%
Inventories
903.85
2,560.42
-1,656.57
-64.70%
Sundry Debtors
1,182.74
1,873.82
-691.08
-36.88%
Cash and Bank
176.24
344.23
-167.99
-48.80%
Other Current Assets
76.82
110.82
-34.00
-30.68%
Short Term Loans and Advances
64.67
314.36
-249.69
-79.43%
Total Current Assets
2,843.03
5,967.04
-3,124.01
-52.35%
Net Current Assets (Including Current Investments)
1,846.93
3,580.82
-1,733.89
-48.42%
Total Current Assets Excluding Current Investments
2,404.32
5,203.65
-2,799.33
-53.80%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
4,828.52
11,743.63
-6,915.11
-58.88%
Contingent Liabilities
8.12
268.69
-260.57
-96.98%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
302.38
273.88
28.50
10.41%
Annual - Borrowings
Borrowings 2.59 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 73.83% vs 4.20% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 37.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 38.71% vs -4.89% in Mar 2024

Annual - Fixed Assets
Fixed Assets 1,847.66 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 11.62% vs 1.86% in Mar 2024

Annual - Investments
Investments 25.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 35.84% vs -25.98% in Mar 2024

Annual - Current Assets
Current Assets 2,843.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.11% vs -3.64% in Mar 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."